Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents
Authors:
- Bixue XuBXBixue Xu
- Zhengming HuangZHZhengming Huang
- Weidong PanWPWeidong Pan
- Peixue CaoPCPeixue Cao
- Changxiao LiuCLChangxiao Liu
- Xiaojiang HaoXHXiaojiang Hao
- Baoan SongBSBaoan Song
- Guangyi LiangGLGuangyi Liang
- 1 September 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (18) , 5352-5360
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30760292)
- Ministry of Science and Technology of China (2011ZX09102-009-2)
- Science and Technology Department of Guizhou Province (QKHZYZ [2010] 5018)
This publication has 16 references indexed in Scilit:
- Entecavir resistance is rare in nucleoside naïve patients with hepatitis BHepatology, 2006
- Chronic hepatitis B in hepatocarcinogenesisPostgraduate Medical Journal, 2006
- Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylatesBioorganic & Medicinal Chemistry, 2006
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensationJournal of Hepatology, 2005
- Clinical Trial Results of New Therapies for HBV: Implications for Treatment GuidelinesSeminars in Liver Disease, 2005
- Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measuresJournal of Viral Hepatitis, 2004
- Lamivudine resistance in hepatitis B: mechanisms and clinical implicationsDrug Resistance Updates, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- Long-term follow-up of anti-HBe-positive chronic active hepatitis BHepatology, 1988